HCPCS Code Descriptor:
Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
Route of Administration:
Vegzelma is an Oncology drug manufactured by Celltrion and administered via the Intravenous route of administration. The Q Code: Q5129 is aligned to the drug Vegzelma.
Vegzelma is an artificial antibody called IgG1 that is used to treat a variety of cancers. This medication works by blocking the VEGF protein in order to slow tumor growth. Vegzelma is manufactured by Celltrion USA and is biosimilar to the medication Avastin (J9035). Vegzelma is aligned to the HCPCS code Q5129, this code was aligned to the drug as of April 2023.